LeafNLP Demos
Back to explore

Report #2879909

Received Dec 30, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
UT
Recovered
Unknown
Vaccinated
Dec 8, 2025
Onset
Dec 8, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKZ008082—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE reported; VARIVAX that experienced excursion was administered to one patient. Excursion occurred 12/5/2025 and date of administration was 12/8/2025.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 08-Dec-2025, the patient was vaccinated with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot # Z008082, expiration date: 28-Apr-2027) (exact dose, route of administration, and anatomical location were not reported) administered for prophylaxis, that underwent temperature excursion. The vaccine was reconstituted with sterile diluent, solution for injection, (lot # and expiration date not reported). The vaccine underwent following temperature excursion: temperature -14 degrees Celsius to -10 degrees Celsius for 45 minutes; -10 degrees Celsius to 8 degrees Celsius (4.1C) for 64 hours. No adverse event was reported.

Other medications

sterile diluent